$1.22 Billion is the total value of Redmile Group, LLC's 55 reported holdings in Q2 2015. The portfolio turnover from Q1 2015 to Q2 2015 was 50.0% .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| ARRY | Buy | ARRAY BIOPHARMA INC | $98,226,000 | +1.5% | 13,623,620 | +3.8% | 8.05% | -7.3% |
| FOLD | Buy | AMICUS THERAPEUTICS INC | $89,110,000 | +40.4% | 6,297,523 | +8.0% | 7.30% | +28.2% |
| VRX | Buy | VALEANT PHARMACEUTICALS INTL | $85,418,000 | +60.2% | 384,506 | +43.2% | 7.00% | +46.2% |
| CLVS | Sell | CLOVIS ONCOLOGY INC | $66,743,000 | -0.2% | 759,479 | -15.7% | 5.47% | -8.9% |
| TEVA | Buy | TEVA PHARMACEUTICAL INDS LTDadr | $57,171,000 | +7.5% | 967,359 | +13.3% | 4.69% | -1.9% |
| AGN | New | ALLERGAN PLC | $41,519,000 | – | 136,818 | +100.0% | 3.40% | – |
| KYTH | Buy | KYTHERA BIOPHARMACEUTICALS I | $36,341,000 | +222.0% | 482,556 | +114.4% | 2.98% | +194.0% |
| HCA | New | HCA HOLDINGS INC | $35,381,000 | – | 390,000 | +100.0% | 2.90% | – |
| ABBV | New | ABBVIE INC | $34,268,000 | – | 510,010 | +100.0% | 2.81% | – |
| AET | Buy | AETNA INC NEW | $33,659,000 | +49.1% | 264,075 | +24.6% | 2.76% | +36.0% |
| CMRX | Sell | CHIMERIX INC | $32,313,000 | +1.5% | 699,425 | -17.2% | 2.65% | -7.3% |
| CI | New | CIGNA CORPORATION | $32,189,000 | – | 198,700 | +100.0% | 2.64% | – |
| BIIB | Sell | BIOGEN INC | $31,959,000 | -22.5% | 79,118 | -19.0% | 2.62% | -29.3% |
| BMRN | New | BIOMARIN PHARMACEUTICAL INC | $28,415,000 | – | 207,744 | +100.0% | 2.33% | – |
| RCPT | Sell | RECEPTOS INC | $27,406,000 | +4.3% | 144,205 | -9.5% | 2.25% | -4.8% |
| JAZZ | Buy | JAZZ PHARMACEUTICALS PLC | $26,563,000 | +53.7% | 150,866 | +50.9% | 2.18% | +40.4% |
| SGEN | Sell | SEATTLE GENETICS INC | $25,613,000 | -31.2% | 529,199 | -49.7% | 2.10% | -37.2% |
| UHS | New | UNIVERSAL HLTH SVCS INCcl b | $25,005,000 | – | 175,965 | +100.0% | 2.05% | – |
| HNT | Buy | HEALTH NET INC | $24,887,000 | +52.2% | 388,128 | +43.6% | 2.04% | +39.0% |
| ALR | Sell | ALERE INC | $24,327,000 | -25.1% | 461,170 | -30.6% | 1.99% | -31.6% |
| NSTG | Buy | NANOSTRING TECHNOLOGIES INC | $22,509,000 | +105.0% | 1,459,742 | +35.5% | 1.84% | +87.1% |
| SAGE | New | SAGE THERAPEUTICS INC | $21,196,000 | – | 290,350 | +100.0% | 1.74% | – |
| INSM | Sell | INSMED INC | $21,181,000 | -26.3% | 867,346 | -37.2% | 1.74% | -32.7% |
| ATRA | Buy | ATARA BIOTHERAPEUTICS INC | $19,661,000 | +78.3% | 372,642 | +40.5% | 1.61% | +62.7% |
| ITCI | Sell | INTRA CELLULAR THERAPIES INC | $19,495,000 | +22.1% | 610,171 | -8.7% | 1.60% | +11.4% |
| GWPH | Buy | GW PHARMACEUTICALS PLCads | $17,938,000 | +65.3% | 146,027 | +22.6% | 1.47% | +50.8% |
| MODN | Sell | MODEL N INC | $17,189,000 | -1.7% | 1,443,278 | -1.3% | 1.41% | -10.3% |
| INCY | New | INCYTE CORP | $17,194,000 | – | 164,995 | +100.0% | 1.41% | – |
| OXFD | Sell | OXFORD IMMUNOTEC GLOBAL PLC | $16,799,000 | -15.7% | 1,212,892 | -14.3% | 1.38% | -23.0% |
| CSLT | Sell | CASTLIGHT HEALTH INCcl b | $16,155,000 | -10.9% | 1,984,631 | -15.1% | 1.32% | -18.7% |
| ZSPH | Sell | ZS PHARMA INC | $15,874,000 | -7.0% | 302,988 | -25.3% | 1.30% | -15.1% |
| ONTY | New | ONCOTHYREON INC | $15,577,000 | – | 4,164,878 | +100.0% | 1.28% | – |
| CIVI | Sell | CIVITAS SOLUTIONS INC | $14,029,000 | -23.8% | 657,693 | -25.2% | 1.15% | -30.5% |
| FATE | New | FATE THERAPEUTICS INC | $12,988,000 | – | 2,007,446 | +100.0% | 1.06% | – |
| DVA | Sell | DAVITA HEALTHCARE PARTNERS I | $11,141,000 | -48.4% | 140,191 | -47.3% | 0.91% | -52.9% |
| BPMC | New | BLUEPRINT MEDICINES CORP | $9,671,000 | – | 378,235 | +100.0% | 0.79% | – |
| AAVL | Buy | AVALANCHE BIOTECHNOLOGIES IN | $8,725,000 | -48.9% | 537,282 | +27.6% | 0.72% | -53.3% |
| PRQR | Sell | PROQR THRAPEUTICS N V | $8,613,000 | -47.6% | 516,690 | -31.2% | 0.71% | -52.2% |
| GNCA | Sell | GENOCEA BIOSCIENCES INC | $8,561,000 | -9.4% | 623,519 | -21.8% | 0.70% | -17.3% |
| FLDM | Sell | FLUIDIGM CORP DEL | $8,427,000 | -64.4% | 348,237 | -38.1% | 0.69% | -67.5% |
| CERS | Sell | CERUS CORP | $8,322,000 | +21.1% | 1,603,427 | -2.7% | 0.68% | +10.5% |
| TRIV | Sell | TRIVASCULAR TECHNOLOGIES INC | $7,835,000 | -53.0% | 1,464,563 | -7.8% | 0.64% | -57.1% |
| PTLA | New | PORTOLA PHARMACEUTICALS INC | $6,955,000 | – | 152,700 | +100.0% | 0.57% | – |
| RARE | Sell | ULTRAGENYX PHARMACEUTICAL IN | $6,904,000 | -66.6% | 67,425 | -79.7% | 0.57% | -69.5% |
| BLCM | Sell | BELLICUM PHARMACEUTICALS INC | $5,065,000 | -45.4% | 238,121 | -46.5% | 0.42% | -50.2% |
| ARRAY BIOPHARMA INCnote 3.000% 6/0 | $5,050,000 | +0.6% | 4,000,000 | 0.0% | 0.41% | -8.2% | ||
| CCXI | Buy | CHEMOCENTRYX INC | $3,920,000 | +2869.7% | 476,293 | +2621.7% | 0.32% | +2575.0% |
| EBIO | Buy | ELEVEN BIOTHERAPEUTICS INC | $3,557,000 | +66.1% | 1,261,260 | +425.5% | 0.29% | +52.1% |
| FLXN | Sell | FLEXION THERAPEUTICS INC | $3,119,000 | -27.0% | 142,483 | -24.9% | 0.26% | -33.2% |
| AXGT | New | AXOVANT SCIENCES LTD | $3,057,000 | – | 150,000 | +100.0% | 0.25% | – |
| NVTA | Sell | INVITAE CORP | $2,563,000 | -76.6% | 181,224 | -76.9% | 0.21% | -78.6% |
| ADRO | New | ADURO BIOTECH INC | $1,870,000 | – | 61,639 | +100.0% | 0.15% | – |
| IHF | ISHARESus hlthcr pr etf | $1,229,000 | +7.4% | 8,599 | 0.0% | 0.10% | -1.9% | |
| CLDX | Sell | CELLDEX THERAPEUTICS INC NEW | $826,000 | -94.6% | 32,765 | -94.0% | 0.07% | -95.0% |
| PPH | MARKET VECTORS ETF TRpharmaceutical | $460,000 | +0.7% | 6,500 | 0.0% | 0.04% | -7.3% | |
| ALXN | Exit | ALEXION PHARMACEUTICALS INC | $0 | – | -1,390 | -100.0% | -0.02% | – |
| QQQ | Exit | POWERSHARES QQQ TRUSTunit ser 1 | $0 | – | -4,300 | -100.0% | -0.04% | – |
| OTIC | Exit | OTONOMY INC | $0 | – | -78,972 | -100.0% | -0.25% | – |
| AKAOQ | Exit | ACHAOGEN INC | $0 | – | -398,340 | -100.0% | -0.35% | – |
| BIOS | Exit | BIOSCRIP INC | $0 | – | -1,378,200 | -100.0% | -0.55% | – |
| NUVA | Exit | NUVASIVE INC | $0 | – | -185,137 | -100.0% | -0.76% | – |
| TKMR | Exit | TEKMIRA PHARMACEUTICALS CORP | $0 | – | -700,000 | -100.0% | -1.10% | – |
| ARAY | Exit | ACCURAY INC | $0 | – | -1,515,475 | -100.0% | -1.26% | – |
| GMED | Exit | GLOBUS MED INCcl a | $0 | – | -611,731 | -100.0% | -1.39% | – |
| WOOF | Exit | VCA INC | $0 | – | -307,804 | -100.0% | -1.52% | – |
| HWAY | Exit | HEALTHWAYS INC | $0 | – | -1,074,033 | -100.0% | -1.90% | – |
| ASPX | Exit | AUSPEX PHARMACEUTICALS INC | $0 | – | -417,533 | -100.0% | -3.76% | – |
| ENDP | Exit | ENDO INTL PLC | $0 | – | -560,443 | -100.0% | -4.51% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2015-08-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| AMICUS THERAPEUTICS INC | 43 | Q3 2023 | 10.1% |
| ATARA BIOTHERAPEUTICS INC | 36 | Q3 2023 | 6.4% |
| FATE THERAPEUTICS INC | 34 | Q3 2023 | 17.2% |
| INVITAE CORP | 32 | Q3 2023 | 2.7% |
| REGENXBIO INC | 28 | Q3 2023 | 3.8% |
| CLOVIS ONCOLOGY INC | 27 | Q1 2020 | 6.7% |
| IMMUNOGEN INC | 27 | Q3 2023 | 13.2% |
| CASTLIGHT HEALTH INC SAN FRAN COM STK | 27 | Q1 2021 | 2.5% |
| ARRAY BIOPHARMA INC | 26 | Q2 2019 | 12.6% |
| DECIPHERA PHARMACEUTICALS IN | 25 | Q3 2023 | 7.0% |
View Redmile Group, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Neoleukin Therapeutics, Inc. | July 27, 2023 | 2,912,228 | 6.6% |
| IGM Biosciences, Inc. | June 28, 2023 | 3,291,092 | 9.9% |
| MedAvail Holdings, Inc. | June 21, 2023 | 124,507,268 | 73.1% |
| Achilles Therapeutics plc | February 14, 2023 | 1,608,089 | 3.9% |
| Kymera Therapeutics, Inc. | February 14, 2023 | 2,673,837 | 4.9% |
| Old Ayala, IncSold out | February 08, 2023 | 0 | 0.0% |
| Zymeworks Inc. | August 08, 2022 | 5,758,241 | 9.9% |
| Science 37 Holdings, Inc. | June 15, 2022 | 19,808,234 | 17.1% |
| Allakos Inc. | February 14, 2022 | 2,077,875 | 3.8% |
| Aprea Therapeutics, Inc.Sold out | February 14, 2022 | 0 | 0.0% |
View Redmile Group, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 4 | 2024-04-01 |
| 4 | 2024-04-01 |
| 4 | 2024-03-25 |
| SC 13D/A | 2024-03-25 |
| 4 | 2024-03-19 |
| 4 | 2024-03-14 |
| 4 | 2024-03-13 |
| SC 13D/A | 2024-03-13 |
| 4 | 2024-03-05 |
| SC 13D/A | 2024-03-05 |
View Redmile Group, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.